Skip to content

A Study on Using Yogic Nasal Cleansing Alongside Standard Treatments for Chronic Sinus Problems

A Prospective Comparative Study to Evaluate the Effects of Jala Neti and Sutra Neti as Add-on Therapy Compared to Standard of Care in Patients with Chronic Sinusitis. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/06/113106
Enrollment
120
Registered
2026-06-29
Start date
Unknown
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J324- Chronic pansinusitis

Interventions

Intervention1: Jala Neti along with Standard Allopathic Treatment: Preparation Use a Neti pot 200ml capacity Dissolve 1 tsp of salt in 400 ml of lukewarm boiled water cooled to body temperature Start

Sponsors

Girish Nehete
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age between 18 to 59 years. For patients who are deemed by ENT specialists to have chronic sinusitis after diagnosis based on the American Academy of Otolaryngology Head and Neck Surgery adult sinusitis guidelines Rosenfeld et al. 2015. Ability to provide informed consent and comply with study procedures.

Exclusion criteria

Exclusion criteria: Pregnancy and breastfeeding. Recent history of cardiovascular events and nasal surgery. Nasal Polyps and gross septal deviation. Smoking patients. Uncontrolled Hypertension Patients. Participation in another clinical trial within the last 30 days. Known allergies or contraindications to any component of the intervention protocols.

Design outcomes

Primary

MeasureTime frame
Change in SNOT-22 and TNSS score from baseline to 10 weeks. CT scan and Clinical checkup reports for Chronic Sinusitis status.Timepoint: The 11 week study protocol consists of a one week sensitization phase followed by six weeks of twice A week active interventions and concludes with a four week follow up period ending in a final clinical check on day 77.

Secondary

MeasureTime frame
Changes in scores and incidence of adverse events.Timepoint: The 11 week study protocol consists of a one week sensitization phase followed by six weeks of twice A week active interventions and concludes with a four week follow up period ending in a final clinical check on day 77.

Countries

India

Contacts

Public ContactDr Brijesh Singh

K. J. Somaiya Medical College and Research Center

srinidhi@somaiya.edu9699693335

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Aug 10, 2026